Chemical Diversity Research Institute (CDRI) - is a unique biotech specialized in combinatorial, medicinal and computational chemistry, and high-throughput screening for early drug discovery. CDRI's goal is the synthesis of the latest advances in chemistry with the unlimited scientific potential and unique experience of Russian researchers.

• Advanced research technologies: computational modeling of interactions between small molecules and their biological targets using advanced data mining algorithms, docking, pharmacophore modeling, etc.; high-throughput liquid- and solid-phase combinatorial synthesis; high-throughput in vitro biological screening of chemical compounds and further optimization of the hits found.
• Experienced staff: 350 specialists, including more than 100 scientists with academic degrees.
• Novel management and logistics technologies.

CDRI collaboration network includes about 100 scientific groups from CIS countries. The Institute has established active cooperation with the Moscow State University, Moscow Institute of Physics and Technology, D. Mendeleev University of Chemical Technology of Russia, etc. CDRI conducts scientific supervision of the young specialists at the stage of their mastership studies. CDRI effectively solves the problem of brain-drain and has repeated examples of Russian specialists who worked for biotechnology in USA and Europe returning to work in their own country.